Holen Sie sich die Stockscreener-App
0.3261
0.88%
-0.0029
Handel nachbörslich:
.31
-0.0161
-4.94%
Schlusskurs vom Vortag:
$0.329
Offen:
$0.31
24-Stunden-Volumen:
554.52K
Relative Volume:
0.42
Marktkapitalisierung:
$13.51M
Einnahmen:
$1.50M
Nettoeinkommen (Verlust:
$-64.59M
KGV:
-0.1953
EPS:
-1.67
Netto-Cashflow:
$-55.17M
1W Leistung:
+1.37%
1M Leistung:
+11.91%
6M Leistung:
-34.79%
1J Leistung:
-84.83%
1-Tages-Spanne:
$0.31
$0.3296
1-Wochen-Bereich:
$0.2848
$0.37
52-Wochen-Spanne:
$0.2223
$4.79
Leap Therapeutics Inc Stock (LPTX) Company Profile
Firmenname
Leap Therapeutics Inc
Sektor
Branche
Telefon
617 252 4343
Adresse
47 THORNDIKE STREET, CAMBRIDGE, MA
Vergleichen Sie LPTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.3261 | 13.63M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.65 | 96.11B | 11.42B | 3.64B | -1.26B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.13 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.14 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.15 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
298.52 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-10-04 | Eingeleitet | Mizuho | Buy |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-06-29 | Eingeleitet | Piper Sandler | Overweight |
| 2020-02-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-11-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | Fortgesetzt | Raymond James | Outperform |
| 2017-03-07 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Leap Therapeutics Inc Aktie (LPTX) Neueste Nachrichten
What makes Leap Therapeutics Inc. stock price move sharplyCapital Safe Picks with Consistent Gains - Newser
Top chart patterns to watch in Leap Therapeutics Inc.Free Weekly Watchlist of High Movers - Newser
What data driven models say about Leap Therapeutics Inc.’s futureSwing Trade Planning with Consistent Setup - Newser
Using R and stats models for Leap Therapeutics Inc. forecastingFast Entry Strategy with Price Prediction - Newser
Real time alert setup for Leap Therapeutics Inc. performanceStock Market Watch with Smart Filters - Newser
How to recover losses in Leap Therapeutics Inc. stockMachine Learning Intraday Signal Forecast - Newser
Analyzing Leap Therapeutics Inc. with multi timeframe chartsFree AI-Powered Trade Planning with Indicators - Newser
Layoff Tracker: Sirona Liquidates TFChem, Merck Will Cut 6,000 Employees - BioSpace
Leap Therapeutics (LPTX.O) Sees Sharp Intraday Drop: What's Behind the Move? - AInvest
Will earnings trigger a reversal in Leap Therapeutics Inc.Free AI Driven Stock Trend Forecast - Newser
What’s next for Leap Therapeutics Inc. stock priceChart Driven Opportunity Scanner with Alerts - Newser
Sentiment Tools Show Shift in Trader Mood on Leap Therapeutics Inc.Exit Ready Momentum Stock Watchlist Expanded - metal.it
Why is Leap Therapeutics Inc. stock attracting strong analyst attentionFree Stock Index Interpretation - Jammu Links News
What is the dividend policy of Leap Therapeutics Inc. stockMaximize returns with strategic portfolio planning - Jammu Links News
Is Leap Therapeutics Inc. a growth stock or a value stockTrack top-performing stocks effortlessly - Jammu Links News
Is Leap Therapeutics Inc. a good long term investmentAmplify your gains with low-risk picks - Jammu Links News
Should I hold or sell Leap Therapeutics Inc. stock in 2025Discover stocks with explosive potential - Jammu Links News
What are Leap Therapeutics Inc. company’s key revenue driversPhenomenal capital gains - Jammu Links News
What is Leap Therapeutics Inc. company’s growth strategyMaximize gains with data-driven trading alerts - Jammu Links News
What are the latest earnings results for Leap Therapeutics Inc.Invest confidently with data-driven strategies - Jammu Links News
Predicting Leap Therapeutics Inc. trend using moving averagesFree Growth Based Stock Signal Screener - newser.com
How does Leap Therapeutics Inc. compare to its industry peersExpert guidance for superior capital growth - Jammu Links News
When is Leap Therapeutics Inc. stock expected to show significant growthDiscover dynamic stocks ready to soar - Jammu Links News
How volatile is Leap Therapeutics Inc. stock compared to the marketBuild a diversified portfolio for steady growth - Jammu Links News
What catalysts could drive Leap Therapeutics Inc. stock higher in 2025Powerful market insights - Jammu Links News
How Leap Therapeutics Inc. stock performs during market volatilityAI Pattern Recognition and Trade Prediction - newser.com
How to integrate Leap Therapeutics Inc. into portfolio analysis toolsDay Trading Plan with Entry Risk Management - Newser
Momentum divergence signals in Leap Therapeutics Inc. chartAlgorithmic Prediction of Market Breakouts - Newser
Using data filters to optimize entry into Leap Therapeutics Inc.Weekly Market Direction and Sector Summary - Newser
Leap Therapeutics Completes Promising Phase 2 Cancer Study, Enhancing Oncology Market Prospects - AInvest
Combining price and volume data for Leap Therapeutics Inc.Smart Chart Forecasting with AI Algorithms - Newser
Is Leap Therapeutics Inc. stock reversal real or fakeAlgorithmic Prediction of Market Breakouts - Newser
Does Leap Therapeutics Inc. qualify in momentum factor screeningBear Market Safe Zone Technical Analysis - Newser
Is Leap Therapeutics Inc. a candidate for recovery playMarket Ready Picks with Technical Support - Newser
Will Leap Therapeutics Inc. stock recover after recent dropReal-Time Entry Forecast with Accuracy Metrics - Newser
Why Leap Therapeutics Inc. stock attracts strong analyst attentionShort-Term Sector Movement Forecast Generator - Newser
Analyzing drawdowns of Leap Therapeutics Inc. with statistical toolsFree Low Risk Buy Zone Opportunity Watch - Newser
Finanzdaten der Leap Therapeutics Inc-Aktie (LPTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):